Nicolas Rousseau

Company: EVerZom

Job title: Co-Founder & Chief Operating Officer

Seminars:

Biopharma Leaders Panel Discussion: Unlocking the Next Wave of Safe & Efficient Exosome-Based Therapeutics Towards Clinical & Commercial Reality 1:30 pm

This is your chance to hear from pioneering executive leaders from the exosome and extra-cellular vesicle community who will discuss their strategies, challenges, and future perspectives for exosome technology and clinically relevant therapeutic applications. What are the future opportunities, promising targets, and applications on the horizon for exosomes to achieve clinical success? What can we…Read more

day: Conference Day One

EVerGel for Crohn Perianal Fistula: Exosomes Embedded in Hydrogel 9:00 am

Showcasing preclinical data in perianal fistula Highlighting quality control and regulatory challenges of a formulation with a hydrogel Outlining the regulatory preparation of a phase 1b/2a clinical trial in Crohn fistula NEW DATA!Read more

day: Conference Day Two

Panel Discussion: Accelerating Scalable & Cost-Effective Extra-Cellular Vesicle Manufacturing for the Development of Therapeutics for Regenerative, Precision & CGT Therapies 11:30 am

Exploring cost-efficient exosome sources such as bodily fluids to reduce the high production costs associated with cellderived exosomes Understanding the complexities involved in setting up pipelines for the purification and production of engineered exosomes to optimize cost considerations throughout the development process Delving into the factors contributing to the cost of engineered exosomes, including production…Read more

day: Conference Day Two